In contrast, gain-of-function SCN2A missense mutations have recently been reported to be associated with early infantile seizures, such as developmental and epileptic encephalopathy (DEE), which usually occur as early as three months of life) [78,81]. The gene discussed is SCN2A; the disease is developmental and epileptic encephalopathy.